Home | News | Events | Contact Us | English | 繁體中文 | 日本語
About Us Product & Service Facilities Quality & Compliance For Investors Career
Latest Events
Latest News
Product & Service
BioTaiwan 2021, Taipei
Booth No. R108, Nov. 04-07, 2021
CPhI Worldwide, Milano, Italy
Nov. 09-11, 2021
US Patent No.US11,021,483 entitled Crystalline of camphorsulfonic acid salt of Rucaparib and method of preparing of tricyclic compounds, Rucaparib and crystalline of camphorsulfonic acid salt of Rucaparib was granted on June 1, 2021. 2021-06-01
TW Patent No. I718533 entitled PREPARATION METHOD OF RIBOCICLIB AND ITS SALT AND CRYSTALLINE FORM THEREOF was granted on Feb 11, 2021. 2021-02-26
Filed US DMF of Ferric Carboxymaltose (#035442, date of submission: Dec. 31, 2020) 2021-01-05
Filed US DMF of Eribulin Mesylate (#035358, date of submission: Nov. 30, 2020) 2021-01-05
US Patent No.US10766900B2 entitled Baricitinib intermediate, method for forming Baricitinib intermediate, and method for preparing Baricitinib or pharmaceutically acceptable salt thereof was granted on Sep 8, 2020. 2020-09-30
Active Pharmaceutical Ingredients
Contract Development and Manufacturing Organization (CDMO)
Antibody Drug Conjugates (ADCs)
Injectable Manufacturing Services



 
Copyright ©2014 Formosa Laboratories, Inc. All Rights Reserved.
丙肝